Overall Technical outlook

Price Summary

On 2026-04-09, MANKIND's stock started at 2039.7, reached a high of 2074.7, fell to 2023.0, and ended 0.71% up at 2054.2, with 232923 shares traded.
The stock reached its highest price of 2696.5 and lowest price of 0.0 over the last 52 weeks.
The price outlook for MANKIND is between 1990.0 and 3110.0, with an average expectation of 2632.0, as estimated by 18 analysts.

Technicals

Support and Resistance: The current price of 2054.2 is supported at 1998.5, with resistance at 2060.5. This suggests that the price for MANKIND might remain between these levels, where 1998.5 acts as a floor and 2060.5 as a ceiling in the market.
MANKIND supportResistance 17de8d
Support/Resistance for MANKIND


Aroon: The AROON is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
MANKIND aroon 17de8d
Aroon chart for Mankind Pharma Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral for MANKIND, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
MANKIND bbands 17de8d
Bolinger Bands chart for Mankind Pharma Limited


Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help maintain the market's upward movement. This strong support suggests that the market is poised to continue its positive trend, providing confidence in the ongoing bullish momentum.
MANKIND psar 17de8d
Parabolic Stop and Reverse chart for Mankind Pharma Limited


Stochastic: The STOCHASTIC is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
MANKIND stoch 17de8d
Stochastic chart for Mankind Pharma Limited


Tripple Moving Agerage: The alignment of the 20-50-100 period moving averages suggests a bullish trend, but the potential for a reversal is hinted at by the slopes of the shorter-term averages. These faster-moving averages show signs of weakening momentum, indicating that while the overall trend is still upward, a reversal could be approaching.
MANKIND trippleSMA 17de8d
Tripple SMA chart for Mankind Pharma Limited


A thorough analysis of a company involves looking at both its fundamentals and technical data. The fundamentals, including revenue, profitability, and management quality, offer insight into the company's long-term value. Additionally, understanding the broader industry context, such as market competition and regulatory challenges, helps to better interpret the company's stock performance. By combining both fundamental and technical analysis, you can derive more meaningful inferences about the company's future prospects.